Lantheus Holdings Inc (LNTH)
65.30
+2.22
(+3.52%)
USD |
NASDAQ |
Apr 23, 15:25
Lantheus Holdings Stock Buybacks (Quarterly): 0.00 for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.993M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.94M |
| December 31, 2022 | 75.00M |
| September 30, 2022 | -0.798M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.577M |
| December 31, 2021 | 0.001M |
| September 30, 2021 | -0.431M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.337M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.317M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.366M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.291M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.282M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.222M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.206M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.187M |
| June 30, 2017 | |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -9.30M |
| September 30, 2016 | -41.60M |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | -73.54M |
| March 31, 2015 | |
| December 31, 2014 | 0.013M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.013M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.067M |
| June 30, 2013 | -0.383M |
| March 31, 2013 | 0.022M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-0.993M
Minimum
Sep 2023
75.00M
Maximum
Dec 2022
3.682M
Average
--
Median
Jun 2019
Stock Buybacks (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -0.364M |
| Eli Lilly and Co | 0.00 |
| Boston Scientific Corp | -- |
| NeuroMetrix Inc | -1.624M |
| Stryker Corp | -- |